#USA #Veeva Systems #Pleasanton #Regeneron Pharmaceuticals #Vault CRM

Regeneron Chooses Veeva Vault CRM Globally

In a significant move towards enhancing its commercial operations, Regeneron Pharmaceuticals has announced its commitment to utilizing Veeva Vault CRM on a global scale. This selection is expected to revolutionize the way Regeneron engages with healthcare professionals and patients, with a special focus on generating valuable commercial evidence through AI-enhanced field engagements.

A New Era of Insights

Veeva Vault CRM is more than just a customer relationship management tool; it integrates multiple applications aimed at optimizing commercial execution within the life sciences space. By harnessing AI, Regeneron aims to uncover underlying barriers that may prevent eligible patients from accessing their medications. This initiative aligns with Regeneron’s mission of delivering transformative therapies for serious diseases, emphasizing their commitment to patient care and innovative science.

Ryan Steinberger, Regeneron's Executive Vice President and Chief Digital and Technology Officer, expressed pride in expanding their strategic collaboration with Veeva. He highlighted that the adoption of Vault CRM enables their commercial teams to have a more interconnected platform, ultimately facilitating faster access to essential information that aids in strategic decision-making.

The Role of Technology in Modern Healthcare

The healthcare landscape continues to evolve, and companies like Regeneron are at the forefront of this transformation. With advancements in technology, there is now an opportunity to gather and analyze data in unprecedented ways. The integration of Agentic Call Reports within Vault CRM ensures that every interaction in the field contributes towards gaining insights that were previously overlooked. These insights become crucial elements of Commercial Evidence, empowering Regeneron to adapt its strategies based on real-world data.

Matt Farrell, President of Commercial Strategy at Veeva, remarked, “We are honored to extend our strategic partnership with Regeneron to include Veeva Vault CRM as they continue to deliver important new medicines to people in need.” This collaboration signifies not only a strategic business move but also a shared commitment to leveraging technology for enhancing patient outcomes.

A Look Ahead

As Veeva Systems focuses on innovation and product excellence, they are committed to addressing the challenges faced by life sciences companies worldwide. The recent alignment with Regeneron marks a pivotal enhancement of their offerings aimed at improving efficiency in commercial practices.

With over 1,500 clients including leading pharmaceutical companies and emerging biotechs, Veeva is dedicated to prioritizing the needs of all stakeholders—customers, employees, and patients alike. As a Public Benefit Corporation, Veeva's approach ensures that its solutions not only meet commercial objectives but also uphold a commitment to societal benefits.

In conclusion, Regeneron’s adoption of Veeva Vault CRM symbolizes a new chapter in their operational strategy, where advanced technology and data analytics come together to create a more efficient and patient-centered healthcare environment. By leveraging these innovations, Regeneron is poised to enhance not only their commercial success but also the accessibility of life-changing medications to those who need them the most.